VITASPRING BIOMEDICAL CO., LTD. Regulated Operating Revenue, Exploration and Production
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Regulated Operating Revenue, Exploration and Production of $248.20 thousand for the 12-month period ending 2021-01-31, per its 10-K filed 2021-04-14.
Discontinued › Income Statement › Other Income
us-gaap:RegulatedOperatingRevenueExplorationAndProduction · last filed 2021-04-14
- VITASPRING BIOMEDICAL CO., LTD. regulated operating revenue, exploration and production for fiscal 2021 was $248.20K, a 1539.37% increase from fiscal 2020.
- VITASPRING BIOMEDICAL CO., LTD. regulated operating revenue, exploration and production for fiscal 2020 was $15.14K.
| Period end | Regulated Operating Revenue, Exploration and Production 12 month |
|---|---|
| 2021-01-31 | $248.20K 10-K · filed 2021-04-14 |
| 2020-01-31 | $15.14K 10-K · filed 2021-04-14 |